Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Power 15 Study: Ventavis Inhalation Times
NCT00467896Phase 2Terminated
- Sponsor
- Actelion Pharmaceuticals Ltd
- Start
- Sep 2006
- Primary completion
- Nov 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of iloprost in pulmonary arterial hypertension (PAH), sponsored by Actelion Pharmaceuticals Ltd. Started Sep 2006; status: terminated.
02
Drugs
iloprost
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT00467896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00467896.